ImmunityBio Inc.
IBRX | NASDAQ
$8.45
-$0.03 (-0.35%)
At close: Sep 21, 2026, 4:00 PM ET
$8.42
-$0.03 (-0.36%)
Pre-market:
Sep 22, 2026, 6:16 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 113.29M | 14.75M | 622K | 240K | 934K | 605K |
Cost of Revenue | 753K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 112.54M | 14.75M | 622K | 240K | 934K | 605K |
Operating Income | -256.03M | -344.18M | -362.25M | -351.3M | -330.28M | -220.88M |
Interest Income | 6.7M | 2.4M | 863K | 2.71M | 836K | 1.73M |
Pretax Income | -351.61M | -413.65M | -583.89M | -417.29M | -349.84M | -226.03M |
Net Income | -351.4M | -413.56M | -583.2M | -416.57M | -346.79M | -221.85M |
Selling & General & Admin | 147.18M | 168.78M | 129.62M | 102.71M | 135.26M | 71.32M |
Research & Development | 207.88M | 190.14M | 232.37M | 248.15M | 195.96M | 139.51M |
Other Expenses | 13.51M | n/a | 886K | 681K | n/a | 10.66M |
Operating Expenses | 368.56M | 358.93M | 362.87M | 351.54M | 331.21M | 221.49M |
Interest Expense | 112.53M | 131.66M | 86.72M | 47.15M | 14.85M | 9.07M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 369.32M | 358.93M | 362.87M | 351.54M | 331.21M | 221.49M |
Income Tax Expense | -135K | n/a | -40K | 34K | 9K | -1.85M |
Shares Outstanding (Basic) | 919.86M | 697.31M | 508.64M | 399.9M | 389.23M | 383.18M |
Shares Outstanding (Diluted) | 919.86M | 700.44M | 508.64M | 399.9M | 389.23M | 383.18M |
EPS (Basic) | -0.38 | -0.59 | -1.15 | -1.04 | -0.89 | -0.59 |
EPS (Diluted) | -0.38 | -0.62 | -1.15 | -1.04 | -0.89 | -0.59 |
EBITDA | -223.56M | -264.43M | -478.66M | -351.88M | -320.75M | -204.22M |
EBIT | -239.08M | -281.99M | -497.18M | -370.14M | -334.99M | -216.96M |
Depreciation & Amortization | 15.53M | 17.55M | 18.51M | 18.26M | 14.24M | 12.74M |
Add to Watchlist
Select watchlists to add or remove IBRX